| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |